找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cancer Immunology and Immunotherapy; Glenn Dranoff Book 2011 The Editor(s) (if applicable) and The Author(s), under exclusive license to S

[复制链接]
查看: 20471|回复: 53
发表于 2025-3-21 19:06:12 | 显示全部楼层 |阅读模式
书目名称Cancer Immunology and Immunotherapy
编辑Glenn Dranoff
视频video
概述The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers an
丛书名称Current Topics in Microbiology and Immunology
图书封面Titlebook: Cancer Immunology and Immunotherapy;  Glenn Dranoff Book 2011 The Editor(s) (if applicable) and The Author(s), under exclusive license to S
描述The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.
出版日期Book 2011
关键词dendritic cells; immune infiltration; regulatory T cells; signal transducer and activator of transcript
版次1
doihttps://doi.org/10.1007/978-3-642-14136-2
isbn_softcover978-3-642-26788-8
isbn_ebook978-3-642-14136-2Series ISSN 0070-217X Series E-ISSN 2196-9965
issn_series 0070-217X
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer-Verlag GmbH, DE
The information of publication is updating

书目名称Cancer Immunology and Immunotherapy影响因子(影响力)




书目名称Cancer Immunology and Immunotherapy影响因子(影响力)学科排名




书目名称Cancer Immunology and Immunotherapy网络公开度




书目名称Cancer Immunology and Immunotherapy网络公开度学科排名




书目名称Cancer Immunology and Immunotherapy被引频次




书目名称Cancer Immunology and Immunotherapy被引频次学科排名




书目名称Cancer Immunology and Immunotherapy年度引用




书目名称Cancer Immunology and Immunotherapy年度引用学科排名




书目名称Cancer Immunology and Immunotherapy读者反馈




书目名称Cancer Immunology and Immunotherapy读者反馈学科排名




单选投票, 共有 1 人参与投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:11:15 | 显示全部楼层
发表于 2025-3-22 00:32:03 | 显示全部楼层
发表于 2025-3-22 08:36:51 | 显示全部楼层
发表于 2025-3-22 10:48:47 | 显示全部楼层
Concepts and Ways to Amplify the Antitumor Immune Response,
发表于 2025-3-22 15:30:12 | 显示全部楼层
Angiogenesis and the Tumor Vasculature as Antitumor Immune Modulators: The Role of Vascular Endothe
发表于 2025-3-22 19:54:52 | 显示全部楼层
发表于 2025-3-22 21:37:11 | 显示全部楼层
发表于 2025-3-23 03:36:40 | 显示全部楼层
Modulation of CTLA-4 and GITR for Cancer Immunotherapy,
发表于 2025-3-23 09:33:44 | 显示全部楼层
Immunobiology of Cancer Therapies Targeting CD137 and B7-H1/PD-1 Cosignal Pathways,
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-6 08:52
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表